date,title,source
Oct-25-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Intersect ENT, Akari Therapeutics, Ampio Pharmaceuticals, Virtusa, Umpqua, and Hamilton Lane  New Research Emphasizes Economic Growth",GlobeNewswire
Nov-15-18,Akari Announces Coversin Data to be Presented at 2018 Complement-Based Drug Development Summit,GlobeNewswire
Nov-15-18,Akari Announces Third Quarter 2018 Financial Results and Business Highlights,GlobeNewswire
Nov-30-18,Akari Therapeutics Announces New Data Highlighting Differentiation of Drug Candidate Coversin,GlobeNewswire
Dec-26-18,"What You Must Know About Akari Therapeutics, Plcs (NASDAQ:AKTX) Beta Value",Simply Wall St.
Jan-29-19,Alexion's Ultomiris Meets Primary Endpoint in aHUS Study,Zacks
Feb-04-19,"Alexion's (ALXN) Earnings Beat Estimates in Q4, Shares Up",Zacks
